Clinical Study

PriZm Therapeutics is shortly beginning a phase III pivotal registration clinical trial of SRW101 in patients with AHDS. This clinical trial will be listed on www.ClinicalTrials.gov once we initiate recruitment, including a list of sites recruiting patients. Our goal is to ensure that eligible patients can access our investigational drug at the appropriate time and in the appropriate manner. If you have questions, please complete the form below.